The Royal New Zealand College of GPs presented and raised a really interesting question, because conceptually this is an off-label - type process under section 23, and they raised the question that with most off-label medicines there's a much more involved and engaged, informed consent process that is required. They had concerns that for the number of vaccines that might be being looked at, that informed consent process for off-label could be cumbersome. Officials replied that the consenting process for the COVID vaccine is now mature, and the college should be reassured that the burden of any new consent will not fall on them—that is, the standing consenting mechanisms should suffice for what is required for this slight variation of off-label.